Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic Remission
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and efficacy of flexibly dosed
paliperidone extended-release (ER) in participants with schizophrenia (psychiatric disorder
with symptoms of emotional instability, detachment from reality, often with delusions and
hallucinations, and withdrawal into the self).